Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(13 sites)

France

CHU de BESANCON, Besançon

CHU de BORDEAUX - Hôpital Pellegrin, Bordeaux

CHU de CAEN, Caen

AP-HP - Hôpital H. Mondor, Créteil

HCL - Hôpital E. Herriot, Lyon

AP-HM - Hôpital de la Conception, Marseille

CHU de NICE, Nice

CHU de Nîmes - Hôpital CAREMEAU, Nîmes

AP-HP - Hôpital Européen Georges Pompidou, Paris

AP-HP - Hôpital Necker, Paris

CHU de TOULOUSE - Hôpital Rangueil, Toulouse

CHRU de TOURS - Hôpital Bretonneau, Tours

CH de Valenciennes, Valenciennes